SEC Filings Details

Overview

Form DEF 14A

05/22/2025

Proxy Statement (definitive)

PDF Format Download (opens in new window)
Excel Format Download (opens in new window)
XBRL Format Download (opens in new window)
XBRL Format Download (opens in new window)

Contact Us

441 Ninth Avenue
14th Floor
New York, NY 10001
United States

For inquiries or to request additional information, please call or email:

(202) 361-0445
IR@Ovidrx.com

Quick Links

SEC Filings

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ovid Therapeutics Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ovid Therapeutics Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News

Quarterly Reports

Annual Reports

SEC Filings

End of Day Stock Quote

Events & Presentations

Unsubscribe

Email Alert Sign Up Confirmation

Terms & Conditions Agreement
Privacy Policy
Cookies Policy